1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Gigantism: new trials by email Literature Review of Gigantism trials Research Report on Gigantism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism Pasireotide LAR - Acromegaly, Pituitary Gigantism | Phase 2 | Completed | Novartis Pharmaceuticals | 33 | 2012-10-16 | 2019-09-16 |
Acromegaly (1) · Growth Disorders (1) · Pituitary Neoplasms (1)
Bone Diseases (1) · Bone Diseases, Developmental (1) · Bone Diseases, Endocrine (1) · Brain Diseases (1) · Brain Neoplasms (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Hyperpituitarism (1) · Hypothalamic Diseases (1) · Hypothalamic Neoplasms (1) · Musculoskeletal Diseases (1) · Neoplasms (1) · Neoplasms by Site (1)
pasireotide (1)
Japan (1)